Raju Prasad - Chief Financial Officer at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

Raju Prasad - trading volume in the past year for CRISPR Therapeutics AG

Holdings reported by Raju Prasad for CRISPR Therapeutics AG

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 6.48K $471K $72.69 Mar 15, 2024 Direct
Stock Option (Right to Buy) 36.2K Mar 20, 2024 Direct Common Shares
Restricted Stock Units 25K Mar 20, 2024 Direct Common Shares

Transactions reported by Raju Prasad for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.